mHealth Market Research Report- Forecast To 2027

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2027

ID: MRFR/HCIT/1284-HCR | February 2021 | Region: Global | 301 pages

mHealth Market Overview


The mHealth market size can be recognized as a branch of eHealth and targets the collection of important data related to the patient. The market services do not focus on manual collection of data instead collect the data with the help of the available electronic means like mobiles and wearable devices along with the other mHealth devices. Also, the data that is collected is further, stored on a remote cloud with the help of the mHealth market applications. The healthcare professionals access this data that helps in analyzing parameters that are associated with the medical condition of the patient. 


Also, the readings collected through these devices are used to understand the severity of the patient’s condition which further helps in taking timely steps related to the patient’s treatment and curing the illness. The mHealth market makes use of a variety of devices like glucose and BP monitors, along with monitors for sleep and cardiac health amongst others. Owing to its consistent use, the mHealth market share is expected to grow at 36.5% CAGR (2016-2022).


COVID 19 Analysis


The arrival of the Covid-19 pandemic has accelerated growth for the medical and healthcare services to a great extent. However, the other industries are struggling with this new change and taking their time to implement them across various industries. The production, manufacturing, and delivery units have suffered the most owing to the travel, operational, and lockdown restrictions. The pandemic has hit the lives of people making them do every step that boosts their immunity. Also, the people who have contracted the illness are either in hospitals or home quarantine. To treat the patients and cure this illness along with others, the patients’ record is a must. This is because the treatment of the patients and the risk quotient are understood with the help of the same. 


The mHealth market devices are being manufactured for wide use for the patients. The collected data through the services of the mHealth market helps in curing the patients and hence, is undergoing development. The key market players are investing in the research and development departments for devices and services to benefit patients and helping them receive the best possible treatment. Also, the government is showing support towards the global growth of the mHealth market with its offered schemes and regulations. 

mHealth market, by Region (%)





Market Dynamics


Drivers


Owing to the increased awareness amongst people for personal healthcare, the patients are getting involved in-depth for their medical condition and provide appropriate information on requirements. Also, the mobile and electronic industry is focusing on the same by developing smartphones, watches, alongside other wearable devices. Also, the healthcare industry inmates are investing in these variables which are helping the mHealth market to grow at a staggering rate.


Restraints


The mHealth market deals in collecting the medical and other important information related to the patient and any family history of diseases. But, while getting the information recorded, the patients feel insecure owing to security and privacy issues. The risk related to misuse and data leaks is high due to which fewer patients sign up for the same. 


Technology Analysis


The development in technology and other scientific advancement has a lot of benefits in store for the healthcare services where collecting and recording the patient’s data holds foremost importance. The key market players are on their way towards the use of wireless technology and integrating the same with the healthcare devices that are employed in the process of data collection. The mHealth market is thus, aiming to put both the doctors and patients in a better state to treat and seek treatment. 


Study Objectives



  • To study the scope of growth of the mHealth market after the pandemic and discussing the drivers and restraints available to the market after considering the viewpoint of the industry leaders and experts

  • To analyze the mHealth market segments functional in different locations across the world and also have an idea about the companies that provide similar services to the potential clients

  • To understand the potential of the market by analyzing the competitive degree prevailing and also considering the steps undertaken by the players towards global growth by the end of the forecast period in 2022 


Segment Overview


To cater to a larger audience and expand its lane of operations, the mHealth market size has been segmented based on the devices, services, stakeholders, applications, along with the global regions. The sub-segmentation is as follows:


Device


Based on the devices, the mHealth market has devices like blood glucose meters, cardiac, neurological, and BP monitors, along with others like wearable fitness sensor devices, and heartbeat meters amongst others. These are both being demanded by the healthcare professionals and patients and further, produced by the key market players in various regions.


Service


The services that are offered through the mHealth market are prevention services, alongside others like monitoring and diagnostics, treatment, surgeries, wellness, and strengthening solutions for healthcare systems.


Stakeholders


The stakeholder segment of the mHealth market includes mobile operators, healthcare service providers, content players, and device vendors.


Application


The application segment of the mHealth market includes diseases like cardiovascular diseases, respiratory issues, diabetes, and neurological issues amongst others. The patients who suffer from these have a higher risk and thus, medical condition information and reports are a must to be collected.


Regional Analysis


As per the mHealth market trends, the North American market enjoyed a major share in the market in 2019, and there is a similar expectation by the end of the forecast period in 2022. The main reason behind this is that the region is witnessing major growth in the rise of the population that is suffering from problems like diabetes, cardiovascular issues, and BP problems. Hence, to help the patients, the key market players in this region are focusing on the development of mobile health devices and services. The patients are thus, demanding the same which is staggering an excellent growth in the global mHealth market. 


The fastest-growing region as per the prediction is the APAC region. The key market players that are functional in this region are focusing on creating and raising awareness related to mobile healthcare services and devices for the patients having major issues and need to visit the hospitals now and then. 


Competitive Landscape


The mHealth market value is largely dependent on the efforts for growth, mergers, and acquisitions, to enhance their product lane, services, and global presence. Also, the growth opportunities and strategies by the market players have a role to play in determining the market valuation by the end of the forecast period in 2022. The prominent players of the market are as follows: 



  • Bayer healthcare

  • Medtronic plc

  • Samsung Group

  • Sanofi

  • Omron Corporation

  • Boston Scientific Corporation

  • Johnson and Johnson

  • Koninklijke Philips N.V.

  • Masimo Corporation

  • Dexcom


 Recent Developments



  • There is a rise in patients suffering from diabetes in the APAC region which is staggering for the demand for mobile devices and services. This is one of the major reasons due to which the APAC region is expected to experience the fastest growth amongst others in competition.

  • The developing economies that offer mHealth solutions and services are aiming toward giving tough competition globally during the current forecast period ending in 2022. They are opting to adopt lucrative offers and opportunities that will help them to expand their scale of operations.

  • The Middle East and African countries are open to mergers and acquisitions that will provide them with an opportunity to aware their population about the mHealth services and also make use of these solutions for curating a good, reliable, and qualitative healthcare system.

  • The North American players are largely focusing on the development of innovative devices and solutions that will push their target audience to invest and demand these devices on a global scale.


Intended Audience



  • Mobile operators and vendors

  • Device vendors

  • Application enthusiasts

  • Content players

  • Healthcare service providers and other staff

  • Patients


Report Overview


The global mhealth market report discusses the impact of the pandemic on the market operations and depicts the dynamics like growth drivers and restraints on the way. The report considers the viewpoint of the industry experts and market leaders to procure the market insights that help in portraying a clear picture of the market for the forecast period ending in 2022. The report aims to help the investors and experts make better decisions and hence, the report discusses the market segmentation and their potential to meet the demand in the global regions they are currently functional in. Through the report, the aim is to study the competition prevailing in the market and for the same, the growth strategies by the market players are analyzed and the recent developments of the market for a global presence are also discussed.



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2022- USD 21.71Billion
  • 2027: Significant Value
  •   CAGR   36.5% (2016-2022)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Therapeutics, Applications, End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Agamatrix, INC, Alivecor, INC, Apple, INC, Athenahealth INC, AT&T, INC, Biotelemetry INC. (CARDIONET), GE Healthcare, Google INC, Jawbone INC, Johnson & Johnson, Laboratory Corporation of America Holdings, Philips Healthcare and others.
      Key Market Opportunities    New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Patient’s involvement in personal healthcare
  • Implementation of smartphones and wearable devices into healthcare industry
  • Integration of wireless technologies with healthcare devices that are portable
  • Benefits of Cost effectiveness and patients’ convenience
  • Increase in lifestyle diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Mobile health or mHealth is the practice use of mobile devices for the purpose of health services, information, and data collection. mHealth has emerged as a booming field due to advancements in the use of information and communication technology (ICT), for health services and information.

    The mHealth market is expected to reach USD 21.71BN by 2022.

    The mHealth market is expected to register a whopping CAGR over 34% throughout the assessment period (2016-2022).

    Implementation of smartphones and wearable devices into the healthcare industry.

    North America holds the largest share in the mHealth market followed by Asia Pacific and Europe, respectively.

    Alivecor, INC, Agamatrix, INC, Apple, INC, AT&T, INC, Athenahealth INC, Biotelemetry INC. (CARDIONET), Google INC, GE Healthcare, Jawbone INC, Laboratory Corporation of America Holdings, Johnson & Johnson, and Philips Healthcare are some of the major players operating in the global mHealth market.

    1 REPORT SCOPE

    1.1 SCOPE OF THE STUDY

    1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE

    1.1.2 XX RESEARCH METHODOLOGY

    1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY

    1.1.3.1 Geographical Analysis

    1.1.3.2 Demand Side & Supply Side Analysis

    1.1.3.3 Data Synthesis & Bridging

    1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY

    1.1.5 KEY DATA POINT SOURCES

    1.1.5.1 Data Points taken from Secondary Sources

    1.1.5.2 Data Points taken from Primary Sources

    1.1.6 REPORT DESCRIPTION

    2 EXECUTIVE SUMMARY

    3 MARKET OVERVIEW

    3.1 INTRODUCTION

    3.2 MARKET DYNAMICS

    3.2.1 MARKET DRIVERS

    3.2.1.1 Patients Involvement in personal healthcare

    3.2.1.2 Proliferation of Smartphones and wearable devices into healthcare

    3.2.1.3 Integration of wireless technologies with portable healthcare devices

    3.2.1.4 Introduction of connected healthcare solutions in the mHealth market

    3.2.1.5 Benefits of Cost effectiveness and Patients’ Convenience

    3.2.1.6 Increase in Lifestyle Disease

    3.2.2 MARKET CHALLENGES

    3.2.2.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs)

    3.2.2.2 Invasion of Privacy

    3.2.2.2.1 Security Breach Cases

    3.2.2.2.2 Potential risk of Hardware or Software failure

    3.2.2.2.3 Stringent Regulations and Standards

    3.2.2.2.4 Lack of Awareness about the possible applications of mHealth

    3.2.3 MARKET OPPORTUNITIES

    3.2.3.1 Partnership: An entry mode

    3.2.3.2 Introduction of mHealth in developing economies

    4 INDUSTRY DYNAMICS

    4.1 MHEALTH MARKET TIMELINE

    4.2 VALUE CHAIN OF THE MHEALTH MARKET

    4.2.1.1 Device Manufacturers

    4.2.1.2 App Developers

    4.2.1.3 Network providers/ Mobile operators

    4.2.1.4 Healthcare providers and Pharmaceuticals

    4.2.1.5 Patients

    4.2.1.6 Consortiums, Certification, Regulations, & Standards

    4.2.1.6.1 Introduction

    4.2.1.6.2 Consortiums

    4.2.1.6.3 Alliance/Associations

    4.2.1.6.4 Regulatory Bodies

    4.2.1.7 Food and Drug Administration (FDA)

    4.2.1.8 Medical Device Regulation Act

    4.2.1.9 Medical Mobile Application(MMA)

    4.2.2 CERTIFICATION

    4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS

    4.2.4 BARGAINING POWER OF BUYER

    4.2.5 BARGAINING POWER OF SUPPLIER

    4.2.6 THREAT FROM SUBSTITUTE

    4.2.7 THREAT FROM A NEW ENTRANT

    4.2.8 INTENSITY OF COMPETITIVE RIVALRY

    5 GLOBAL MHEALTH MARKET ECOSYSTEM

    5.1 INTRODUCTION

    5.1.1 MHEALTH DEVICES

    5.1.2 MEDICAL DEVICES

    5.1.2.1 SMBG monitor

    5.1.2.1.1 SMBG Device Types& Uses

    5.1.2.1.2 Diseases Managed by SMBG Device

    5.1.2.1.3 Key players

    5.1.2.2 Blood Pressure (BP) Monitor

    5.1.2.2.1 BP Monitor Device Types & Uses

    5.1.2.2.2 Diseases Managed by BP Monitor Device

    5.1.2.2.3 Key players

    5.1.2.2.4 Pulse Oximeter

    5.1.2.2.5 Pulse Oximeter : Types & Uses

    5.1.2.2.6 Diseases Managed by Pulse Oximeter Device

    5.1.2.2.7 Key players

    5.1.2.3 Cardiac Monitors

    5.1.2.3.1 Diseases Managed by Cardiac Monitors

    5.1.2.3.2 Disease Management Devices Types

    5.1.2.3.3 Cardiac Monitor Uses

    5.1.2.4 Key players

    5.1.2.5 Other medical devices

    5.1.2.5.1 Health and Fitness Devices

    5.1.2.5.2 Hand Worn Products

    5.1.2.5.2.1 Smart Watch

    5.1.2.5.2.2 Wrist Wear

    5.1.2.5.3 Key players

    5.1.2.5.4 Head Worn Products

    5.1.2.5.4.1 AR/VR HMD/HUD

    5.1.2.5.4.2 Others

    5.1.2.5.4.3 Body worn products

    5.1.2.5.4.4 Smart Textile

    5.1.2.5.4.5 Wearable Patch

    5.1.2.5.4.6 Others

    5.1.2.5.5 Non-Clinical applications

    5.1.2.5.6 Clinical Application

    5.1.2.6 Others Devices

    5.1.2.6.1 Mobile telemedicine/tele-care devices

    5.1.2.6.2 Home care devices

    5.1.2.6.2.1 Vessyl

    5.1.2.6.2.2 TAO

    5.1.2.6.2.3 CubeSensors

    5.1.2.6.2.4 Kolibree

    5.1.2.6.2.5 TellSpec

    5.1.2.6.2.6 Kinsa

    5.1.2.6.2.7 Beddit

    5.1.2.6.2.8 Wello iPhone Case

    5.1.2.6.3 Key Participants

    5.1.2.7 mHealth Services

    5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION

    5.1.3.1 Software

    5.1.3.2 Big data

    5.1.3.3 Key Market Trends, Developments and Participants

    5.1.3.3.1 Market Trends and Market Developments

    5.1.3.3.2 Key Participants

    5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS

    5.1.4.1 Benefits of network & Services

    5.1.4.2 Key Market Trends, Developments and Participants

    5.1.4.2.1 Market Trends and Market Developments

    5.1.4.2.2 Key Participants

    5.1.5 HEALTHCARE AND PHARMACEUTICALS

    5.1.5.1 Healthcare providers

    5.1.5.2 Pharmaceuticals

    5.1.5.2.1 Key Market Trends, Developments and Participants

    5.1.5.2.1.1 Market Trends and Market Developments

    5.1.5.2.1.2 Key Participants

    6 GLOBAL MHEALTHMARKET – THERAPEUTICS

    6.1 INTRODUCTION

    6.1.1 GLOBAL MARKET STATISTICS

    6.1.1.1 Cardiovascular Diseases

    6.1.2 DEVICES

    6.1.3 APPS

    6.1.4 KEY PLAYERS

    6.2 DIABETES

    6.2.1 DEVICES

    6.2.2 APPS

    6.2.3 KEY PLAYERS

    6.3 RESPIRATORY

    6.3.1 DEVICES

    6.3.2 APPS

    6.3.3 KEY PLAYERS

    6.4 MENTAL AND NEUROLOGICAL DISORDERS

    6.4.1 DEVICES

    6.4.2 APPS

    6.4.3 KEY PLAYERS

    6.5 FITNESS & LIFESTYLE THERAPEUTICS

    6.5.1 DEVICES

    6.5.2 APPS

    6.5.3 KEY PLAYERS

    6.6 OTHERS

    7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE

    7.1 INTRODUCTION

    7.1.1 MONITORING APPLICATIONS

    7.1.1.1 Key Participants

    7.1.2 DIAGNOSIS & TREATMENT

    7.1.2.1 Key Participants

    7.1.3 EDUCATION AND AWARENESS

    7.1.3.1 Key Participants

    7.1.4 HEALTHCARE MANAGEMENT

    7.1.5 WELLNESS & PREVENTION

    7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET

    7.1.7 REMOTE DATA COLLECTION

    7.1.7.1 Key Market Developments

    8 GLOBAL MHEALTH MARKET–GEOGRAPHY

    8.1 INTRODUCTION

    8.1.1 MARKET STATISTICS

    8.1.2 THE AMERICAS

    8.1.3 NORTH AMERICA

    8.1.3.1 U.S.

    8.1.3.1.1 Key Market trends, Developments and Participants

    8.1.3.1.1.1 Key Market Trends and Developments

    8.1.3.1.1.2 Key Participants

    8.1.3.2 Canada

    8.1.3.2.1 Key Market Trend

    8.1.3.2.2 Key players

    8.1.3.3 South America

    8.1.3.3.1 Constraints

    8.1.3.3.2 Key Market Trends, Developments and Participants

    8.1.3.3.2.1 Market Trends and Market Developments

    8.1.3.3.2.2 Key Participants

    8.1.4 ASIA-PACIFIC (APAC)

    8.1.4.1 Key Drivers in APAC

    8.1.4.1.1 Key Market Trends, Developments and Participants

    8.1.4.1.1.1 Market Trends & Development

    8.1.4.1.1.2 Key Participants

    8.1.4.2 CHINA

    8.1.4.3 JAPAN

    8.1.4.4 AUSTRALIA

    8.1.4.5 INDIA

    8.1.5 EUROPE

    8.1.5.1 Key Market Trends, Developments and Participants

    8.1.5.2 The U.K.

    8.1.5.3 Germany

    8.1.5.4 Key Participants

    8.1.6 REST OF THE WORLD (ROW)

    8.1.6.1 Africa

    8.1.6.1.1 Key Market Trends, Developments and Participants

    8.1.6.1.1.1 Market Trends and Market Developments

    8.1.6.1.2 Key Participants

    8.1.7 MIDDLE EAST

    8.1.7.1 Key Market Trends, Developments and Participants

    8.1.7.1.1 Market Trends and Market Developments

    8.1.7.1.2 Key Participants

    9 KEY MARKET DEVELOPMENT AND STRATEGIES

    9.1 INTRODUCTION

    9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

    9.1.2 MERGERS & ACQUISITIONS

    9.1.3 PRODUCT DEVELOPMENT AND LAUNCH

    9.1.4 BUSINESS EXPANSION/CONTRACTS

    9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS

    9.1.6 OTHERS (EVENTS & RECOGNITIONS)

    10 COMPANY PROFILES

    1.1 AGAMATRIX, INC.

    10.1.1 OVERVIEW

    10.1.2 FINANCIALS

    10.1.3 KEY DEVELOPMENTS

    10.2 ALIVECOR, INC.

    10.2.1 OVERVIEW

    10.2.2 FINANCIALS

    10.2.3 KEY DEVELOPMENTS

    10.3 APPLE, INC.

    10.3.1 OVERVIEW

    10.3.2 FINANCIALS

    10.3.2.1 Overall Financials

    10.3.2.2 Financials By Segment

    10.3.2.3 Financials By Region

    10.3.2.4 Financial Summary

    10.3.3 KEY DEVELOPMENT

    10.4 ATHENAHEALTH INC.

    10.4.1 OVERVIEW

    10.4.2 FINANCIALS

    10.4.2.1 Overall Financials

    10.4.2.2 Financial by Segments

    10.4.2.3 Financial Summary

    10.4.3 KEY DEVELOPMENT

    10.5 AT&T, INC.

    10.5.1 OVERVIEW

    10.5.2 FINANCIALS

    10.5.2.1 Overall Financials

    10.5.2.2 Financials By Segment

    10.5.2.3 Financial Summary

    10.5.3 KEY DEVELOPMENTS

    10.6 BIOTELEMETRY, INC. (CARDIONET)

    10.6.1 OVERVIEW

    10.6.2 FINANCIALS

    10.6.2.1 Overall Financials

    10.6.2.2 Financials by Segment

    10.6.2.3 Financial Summary

    10.6.3 KEY DEVELOPMENTS

    10.7 GE HEALTHCARE

    10.7.1 OVERVIEW

    10.7.2 FINANCIALS

    10.7.2.1 Overall Financials

    10.7.2.2 Financials by Segment

    10.7.2.3 Financial Summary

    10.7.3 KEY DEVELOPMENTS

    10.8 GOOGLE INC.

    10.8.1 OVERVIEW

    10.8.2 FINANCIALS

    10.8.2.1 Financial Summary

    10.8.3 KEY DEVELOPMENTS

    10.9 JAWBONE, INC.

    10.9.1 OVERVIEW

    10.9.2 FINANCIALS

    10.9.3 KEY DEVELOPMENTS

    10.1 JOHNSON & JOHNSON

    10.10.1 OVERVIEW

    10.10.2 FINANCIALS

    10.10.2.1 Overall Financials

    10.10.2.2 Net Revenue By Segment

    10.10.2.3 Net revenue by Region

    10.10.3 KEY DEVELOPMENTS

    10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS

    10.11.1 OVERVIEW

    10.11.2 FINANCIALS

    10.11.2.1 Overall Financials

    10.11.2.2 Financials by Segment

    10.11.2.3 Financial Summary

    10.11.3 KEY DEVELOPMENTS

    10.12 MEDTRONIC PLC

    10.12.1 OVERVIEW

    10.12.2 FINANCIALS

    10.12.2.1 Overall Financials

    10.12.2.2 Financial Summary

    10.12.3 KEY DEVELOPMENTS

    10.13 NIKE INC.

    10.13.1 OVERVIEW

    10.13.2 FINANCIALS

    10.13.2.1 Overall Financials

    10.13.2.2 Financials by Segments

    10.13.2.3 Financial Summary

    10.13.3 KEY DEVELOPMENTS

    10.14 PFIZER

    10.14.1 OVERVIEW

    10.14.2 FINANCIALS

    10.14.2.1 Overall Financials

    10.14.2.2 Financials by Segment

    10.14.2.3 Financials By Region

    10.14.2.4 FINANCIAL SUMMARY

    10.14.3 KEY DEVELOPMENTS

    10.15 PHILIPS HEALTHCARE

    10.15.1 OVERVIEW

    10.15.2 FINANCIALS

    10.15.2.1 Overall Financials

    10.15.2.2 Financials By Region

    10.15.2.3 Financials By Segment

    10.15.2.4 Financial Summary

    10.15.3 KEY DEVELOPMENTS

    10.16 QUALCOMM, INC.

    10.16.1 OVERVIEW

    10.16.2 FINANCIALS

    10.16.2.1 Overall Financials

    10.16.2.2 Financials By Segment

    10.16.2.3 Financials By Region

    10.16.2.4 Financial Summary

    10.16.3 KEY DEVELOPMENTS

    10.17 QUEST DIAGNOSTICS INC.

    10.17.1 OVERVIEW

    10.17.2 FINANCIALS

    10.17.2.1 Overall Financials

    10.17.2.2 Financials by Segment

    10.17.2.3 Financial Summary

    10.17.3 KEY DEVELOPMENTS

    10.18 ROCHE HOLDING AG-BR

    10.18.1 OVERVIEW

    10.18.2 FINANCIALS

    10.18.2.1 Overall Financials

    10.18.2.2 Financials by Segment

    10.18.2.3 Financial Summary

    10.18.3 KEY DEVELOPMENTS

    10.19 SAMSUNG ELECTRONICS CO. LTD.

    10.19.1 OVERVIEW

    10.19.2 FINANCIALS

    10.19.2.1 Overall financials

    10.19.2.2 Financial Summary

    10.19.3 KEY DEVELOPMENTS

    10.2 SANOFI PHARMA

    10.20.1 OVERVIEW

    10.20.2 FINANCIALS

    10.20.2.1 Overall Financials

    10.20.3 FINANCIALS BY SEGMENT

    10.20.4 FINANCIAL SUMMARY

    10.20.5 KEY DEVELOPMENTS

    10.21 WITHINGS SAS

    10.21.1 OVERVIEW

    10.21.2 FINANCIALS

    10.21.3 KEY DEVELOPMENTS


    LIST OF TABLES


    TABLE 1L EADING COMPANIES IN THE MHEALTH MARKET

    TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2020-2027)

    TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS

    TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM

    TABLE 5 CONSORTIUMS IN MHEALTH MARKET

    TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET

    TABLE 7 REGULATORY BODIES IN MHEALTH MARKET

    TABLE 8 MHEALTH MARKET CERTIFICATIONS

    TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER

    TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER

    TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE

    TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT

    TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION

    TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2020-2027 ($MILLION)

    TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2020-2027 ($MILLION)

    TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2020-2027 ($MILLION)

    TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2027-2027 ($MILLION)

    TABLE 19 KEY DEVELOPMENTS

    TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS

    TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT

    TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 25 TYPE OF APP

    TABLE 26 KEY DEVELOPMENTS

    TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 29 KEY DEVELOPMENTS

    TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 42 REMOTE MONITORING IN GEOGRAPHIES

    TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2027-2027 ($MILLION)

    TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2027-2027 ($MILLION)

    TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES

    TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2027-2027 ($MILLION)

    TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES

    TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES

    TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES

    TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

    TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 62 MHEALTH: KEY DEVELOPMENTS (2020- 2027)

    TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

    TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)

    TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 67 THE U.S.: KEY DEVELOPMENTS

    TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2020-2027)

    TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 71 KEY DEVELOPMENTS IN APAC

    TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT

    TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)

    TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

    TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

    TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS (2020-2027)

    TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2020-2027)


    LIST OF FIGURES


    FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA

    FIGURE 2 XX RESEARCH METHODOLOGY

    FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET

    FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY

    FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2020-2027 ($MILLION)

    FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2020-2027 ($MILLION)

    FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2020-2027 ($MILLION)

    FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2020-2027 ($MILLION)

    FIGURE 9 MARKET DRIVERS AND CHALLENGES

    FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS

    FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS

    FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS

    FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS

    FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS

    FIGURE 15 VALUE CHAIN

    FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS

    FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES

    FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS

    FIGURE 19 MHEALTH ECOSYSTEM

    FIGURE 20 TYPE OF MHEALTH DEVICES

    FIGURE 21 SMBD DEVICE USES

    FIGURE 22 USES OF BP MONITORING DEVICE

    FIGURE 23 PULSE OXIMETER USES

    FIGURE 24 WEARABLE DEVICE COMPONENTS

    FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES

    FIGURE 26 HAND WORN MHEALTH DEVICES

    FIGURE 27 APPLE WATCH FIGURE

    FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS

    FIGURE 29 GOOGLE’S CONTACT LENS

    FIGURE 30 HEAD WORN DEVICES

    FIGURE 31 ELECTRONIC FINGERTIP

    FIGURE 32 COMPONENTS OF BIOSTAMP

    FIGURE 33 MYO ARMBAND BY THALMIC LABS

    FIGURE 34 NON-CLINICAL BENEFITS

    FIGURE 35 WEARABLE MEDICAL DEVICES

    FIGURE 36 FITNESS TRACKING DEVICES

    FIGURE 37 TYPES OF MHEALTH SERVICES

    FIGURE 38 TYPES OF APPS

    FIGURE 39 BENEFITS OF BIG DATA

    FIGURE 40 BENEFITS OF NETWORK & SERVICES

    FIGURE 41 ROLES OF MOBILE OPERATORS

    FIGURE 42 ROLE OF HEALTHCARE PROVIDERS

    FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS

    FIGURE 44 BENEFITS OF MHEALTH IN CVDS

    FIGURE 45 BENEFITS OF MHEALTH

    FIGURE 46 BENEFITS OF MHEALTH

    FIGURE 47 BENEFITS OF MHEALTH

    FIGURE 48 BENEFITS OF MHEALTH

    FIGURE 49 TYPES OF MHEALTH APPLICATION

    FIGURE 50 ADVANTAGES OF REMOTE MONITORING

    FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES

    FIGURE 52 EDUCATION & AWARENESS SERVICES

    FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT

    FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY

    FIGURE 55 APAC: MARKET DRIVERS

    FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2020)

    FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS (2020)

    FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2020)

    FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2020)

    FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS (2020)

    FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2020-2027

    FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2020-2027

    FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2020-2027 ($MILLION)

    FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2020-2027

    FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027

    FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2020-2027

    FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027

    FIGURE 72 GE HEALTHCARE SEGMENT, 2027

    FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2020 - 2027 ($BILLION)

    FIGURE 74 J&J: OVERALL FINANCIALS, 2020 - 2027 ($ BILLION)

    FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2020-2027

    FIGURE 76 NET REVENUE BY SEGMENTS, 2020-2027

    FIGURE 77 NIKE: OVERALL FINANCIALS 2020 - 2027 ($BILLION)

    FIGURE 78 NIKE: REVENUE BY REGION (2020-2027)

    FIGURE 79 PFIZER: OVERALL FINANCIALS, 2020-2027 ($BILLION)

    FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 81 PFIZER: FINANCIALS BY REGION, 2020-2027 ($BILLION)

    FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2020-2027 ($MILLION)

    FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2020-2027 ($MILLION)

    FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2020-2027 ($BILLION)

    FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)

    FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2020-2027 ($MILLION)

    FIGURE 88 QUEST: OVERALL FINANCIALS, 2020-2027 ($MILLION)

    FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2020-2027 ($MILLION)

    FIGURE 90 ROCHE: OVERALL FINANCIALS, 2020-2027 ($BILLION)

    FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2020-2027 ($BILLION)

    FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2020-2027

    FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2020-2027